Search
for
Sort by
Research 841–870 of 1000+
- Polycystic Ovary Syndrome
- Is COVID-19 Gender-sensitive?
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Hormone replacement therapy and the skin
- Endocrine control of benign prostatic hyperplasia
- Hair Loss After Routine Immunizations
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- Safety of testosterone treatment in postmenopausal women
- Androgen receptors and their biology
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Menopause and aging, quality of life and sexuality
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- The hair cycle and its regulation
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Sensitive skin
- Congenital adrenal hyperplasia
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Phototrichogram analysis of normal scalp hair characteristics with aging
- Medicinal Plants and their Constituents in the Treatment of Acne vulgaris
- Post-finasteride syndrome
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- The Evaluation and Management of Hirsutism
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Pharmacological management of polycystic ovary syndrome
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- A machine learning and network framework to discover new indications for small molecules